Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B

Background The PAGE-B score (Platelet Age GEnder-HBV) selects chronic hepatitis B (cHB) patients showing no relevant 5-year risk for hepatocellular carcinoma (HCC). We, therefore, explored potential cost reduction following the introduction of a PAGE-B tailored ultrasound screening in a single cente...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC health services research 2021-08, Vol.21 (1), p.1-846, Article 846
Hauptverfasser: Sprinzl, Martin F., Feist, Christina, Koch, Sandra, Kremer, Wolfgang M., Lackner, Karl J., Weinmann, Arndt, Galle, Peter R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The PAGE-B score (Platelet Age GEnder-HBV) selects chronic hepatitis B (cHB) patients showing no relevant 5-year risk for hepatocellular carcinoma (HCC). We, therefore, explored potential cost reduction following the introduction of a PAGE-B tailored ultrasound screening in a single center cohort of cHB patients receiving stable antiviral therapy. Methods cHB patients attending throughout the year 2018 were documented. Patients eligible for PAGE-B score were classified into high (>= 18 points), intermediate (10-17 points) and low (
ISSN:1472-6963
1472-6963
DOI:10.1186/s12913-021-06794-6